Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
Soja AM, Zwisler AD, Frederiksen M, Melchior T, Hommel E, Torp-Pedersen C, Madsen M. Soja AM, et al. Among authors: madsen m. Am Heart J. 2007 Apr;153(4):621-8. doi: 10.1016/j.ahj.2007.01.030. Am Heart J. 2007. PMID: 17383302 Clinical Trial.
A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial)--design, intervention, and population.
Zwisler AD, Schou L, Soja AM, Brønnum-Hansen H, Gluud C, Iversen L, Sigurd B, Madsen M, Fischer-Hansen J; DANREHAB group. Zwisler AD, et al. Among authors: madsen m. Am Heart J. 2005 Nov;150(5):899. doi: 10.1016/j.ahj.2005.06.010. Am Heart J. 2005. PMID: 16290957 Clinical Trial.
Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial.
Zwisler AD, Soja AM, Rasmussen S, Frederiksen M, Abedini S, Appel J, Rasmussen H, Gluud C, Iversen L, Sigurd B, Madsen M, Fischer-Hansen J; DANREHAB Group. Zwisler AD, et al. Among authors: madsen m. Am Heart J. 2008 Jun;155(6):1106-13. doi: 10.1016/j.ahj.2007.12.033. Epub 2008 Mar 14. Am Heart J. 2008. PMID: 18513526 Clinical Trial.
Register-based studies of cardiovascular disease.
Abildstrøm SZ, Torp-Pedersen C, Madsen M. Abildstrøm SZ, et al. Among authors: madsen m. Scand J Public Health. 2011 Jul;39(7 Suppl):165-9. doi: 10.1177/1403494810396559. Scand J Public Health. 2011. PMID: 21775377 Review.
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C. Schramm TK, et al. Among authors: madsen m. Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31. Circulation. 2008. PMID: 18378618
Clarithromycin use and risk of death in patients with ischemic heart disease.
Andersen SS, Hansen ML, Norgaard ML, Folke F, Fosbøl EL, Abildstrøm SZ, Raunsø J, Madsen M, Køber L, Gislason GH, Torp-Pedersen C. Andersen SS, et al. Among authors: madsen m. Cardiology. 2010;116(2):89-97. doi: 10.1159/000315394. Epub 2010 Jun 5. Cardiology. 2010. PMID: 20523043
1,472 results